Literature DB >> 16696516

Follicular dendritic cell sarcoma of lymph node--a rare entity.

Safoorah Khalid1, Nausheen Yaqoob, Shahid Pervez.   

Abstract

Follicular dendritic cells (FDC) are non-lymphoid, non-phagocytic accessory cells in the immune system that are essential for antigen presentation and germinal center reaction regulation. These cells are CD21+, CD35+, CD1a- and S100 protein +/- and they show desmosomes ultrastructurally. The most commonly involved sites by FDC tumors are lymph nodes but may arise at a variety of extranodal sites including oral cavity, tonsil, gastrointestinal tract and liver. Most studies represent single case reports or case series. Our patient presented with tumor in the lymph nodes. Histology revealed tumor cells with abundant eosinophilic cytoplasm, hyperchromatic and pleomorphic nuclei, and prominent nucleoli. The tumor cells were found to be positive for CD21 which is a specific marker for follicular dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696516

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Dendritic cell tumor in a salivary gland lymph node: a rare differential diagnosis of salivary gland neoplasms.

Authors:  Sebastian P Schraven; Stefan K Plontke; Roland Syha; Falko Fend; Hartwig Wolburg; Patrick Adam
Journal:  Diagn Pathol       Date:  2011-09-30       Impact factor: 2.644

Review 2.  Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature.

Authors:  Zheng Su; Gaojie Liu; Jianping Liu; Tingfeng Fang; Yunjie Zeng; Huayao Zhang; Shanglin Yang; Yang Wang; Junmin Zhang; Jinxing Wei; Yingru Li; Youfeng Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin.

Authors:  Francesco Pisani; Mirella Marino; Steno Sentinelli; Maria Concetta Petti
Journal:  J Exp Clin Cancer Res       Date:  2008-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.